Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591589 | SCV000704727 | uncertain significance | not provided | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084887 | SCV001008865 | likely benign | Duchenne muscular dystrophy | 2024-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003343932 | SCV004050855 | likely benign | Cardiovascular phenotype | 2023-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001834887 | SCV002080253 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-04-15 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004543352 | SCV004772195 | likely benign | DMD-related disorder | 2019-11-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |